CHROMA THERAPEUTICS
Chroma Therapeutics is a privately-held biotechnology company focused on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. Chroma is the first company to systematically assemble intellectual property in chromatin biology and has established a strong network of academic collaborators. Chroma aims to build substantial shareholder value through the creation of a broad and innovative product pipeline aimed at the treatment of high-prevalence cancers and inflammatory disorders.
CHROMA THERAPEUTICS
Social Links:
Industry:
Biotechnology Developer Platform Information Services
Founded:
2000-01-01
Address:
Oxton, York, United Kingdom
Country:
United Kingdom
Website Url:
http://www.chromatherapeutics.com
Total Employee:
51+
Status:
Closed
Contact:
+441235829120
Email Addresses:
[email protected]
Total Funding:
112.39 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Current Employees Featured
Founder
Investors List
Hercules Capital
Hercules Capital investment in Debt Financing - Chroma Therapeutics
Wellcome Trust
Wellcome Trust investment in Series D - Chroma Therapeutics
Gilde IT Fund
Gilde IT Fund investment in Series D - Chroma Therapeutics
Nomura Holdings
Nomura Holdings investment in Series D - Chroma Therapeutics
Abingworth
Abingworth investment in Series D - Chroma Therapeutics
Essex Woodlands Healthcare Partners
Essex Woodlands Healthcare Partners investment in Series D - Chroma Therapeutics
GlaxoSmithKline
GlaxoSmithKline investment in Series D - Chroma Therapeutics
Phase4 Ventures
Phase4 Ventures investment in Series C - Chroma Therapeutics
Essex Woodlands Healthcare Partners
Essex Woodlands Healthcare Partners investment in Series C - Chroma Therapeutics
Wellcome Trust
Wellcome Trust investment in Series C - Chroma Therapeutics
Official Site Inspections
http://www.chromatherapeutics.com
Unable to get host informations!!!
More informations about "Chroma Therapeutics"
nChroma Bio
NChroma Bio is a pioneering biotechnology company advancing the development of both best-in-class cargo and targeted in vivo delivery technologies to realize the full potential of genetic medicines.See details»
Chroma Therapeutics - Crunchbase Company Profile
Chroma Therapeutics is a privately-held biotechnology company focused on the discovery and development of novel small molecule drugs based upon …See details»
Chroma Therapeutics - VentureRadar
"Chroma Therapeutics is a privately-held biotechnology company focused on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell …See details»
Chroma Therapeutics (Tosedostat and certain related assets) 2025 ...
Oct 27, 2014 Information on acquisition, funding, cap tables, investors, and executives for Chroma Therapeutics (Tosedostat and certain related assets). Use the PitchBook Platform to …See details»
Chroma Therapeutics 2025 Company Profile: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Chroma Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Chroma Therapeutics is focused on the R&D of novel small …
Chroma Therapeutics is a privately-held biotechnology company focused on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell …See details»
Chroma Therapeutics - EquityNet
Chroma Therapeutics is a privately-held biotechnology company focused on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell …See details»
Chroma Therapeutics - Funding, Financials, Valuation & Investors
Chroma Therapeutics is focused on the R&D of novel small molecule drugs based on chromatin biology and cell accumulation.See details»
Chroma Therapeutics Ltd. - Life-Sciences-Europe.com
Chroma Therapeutics, based in Oxford (UK), is a drug discovery and development company focused in the fields of oncology and inflammatory disorders. Chroma is building a broad …See details»
CHROMA THERAPEUTICS LIMITED overview - Find and update …
CHROMA THERAPEUTICS LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, …See details»
Chroma Therapeutics Ltd. - CMOCRO
Chroma Therapeutics is a privately-held biotechnology company focused on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell …See details»
Chroma Therapeutics - VentureRadar
Chroma Therapeutics is a privately-held biotechnology company focused on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell …See details»
Chroma Therapeutics - Gilde Healthcare
Mar 4, 2013 Chroma Therapeutics discovers and develops novel small-molecule drugs for the treatment of common cancers and inflammatory disorders. Gilde joined the company as one of …See details»
Chroma Therapeutics - Overview, News & Similar companies
View Chroma Therapeutics (www.chromatherapeutics.com) location in Oxfordshire, United Kingdom , revenue, industry and description. Find related and similar companies as well as …See details»
Chroma Therapeutics - Crustdata Company Profile, Funding and …
Chroma Therapeutics is a privately-held biotechnology company focused on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell …See details»
Chroma Therapeutics Company Overview, Contact Details
May 5, 2010 Learn more about Chroma Therapeutics's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»
Chroma Medicine, Nvelop Therapeutics merge to form nChroma Bio
Dec 20, 2024 Chroma Medicine and Nvelop Therapeutics have merged to form nChroma Bio. nChroma will develop Chroma’s epigenetic editing platform and Nvelop’s viruslike delivery …See details»
Chroma Therapeutics - Contacts, Employees, Board Members
Chroma Therapeutics is focused on the R&D of novel small molecule drugs based on chromatin biology and cell accumulation.See details»
Chroma Medicine, Nvelop merge | C&EN Global Enterprise
Dec 23, 2024 Chroma Medicine and Nvelop Therapeutics have merged to form nChroma Bio. nChroma will develop Chroma’s epigenetic editing platform and Nvelop’s viruslike delivery …See details»
Chroma Therapeutics Limited - insights.citeline.com
Jan 31, 2017 The European Investment Bank (EIB) has granted a loan of €24m to F2G Ltd. , the UK-based antifungal development company that was spun out of the University of Manchester …See details»